Grandel; Roland

Patent Applications and Registrations

Patent applications and USPTO patent grants for Grandel; Roland.The latest application filed is for "aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor".

Company Profile

0.30.23

Grandel; Roland - Dossenheim N/A DE
Grandel; Roland - Bad Rappenau N/A DE
Grandel, Roland - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Grant 8,969,552 - Drescher , et al. March 3, 2	2015-03-03
Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor Grant 8,642,642 - Grandel , et al. February 4, 2	2014-02-04
Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor Grant 8,497,273 - Grandel , et al. July 30, 2	2013-07-30
Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor Grant 8,486,984 - Drescher , et al. July 16, 2	2013-07-16
N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor Grant 8,476,275 - Braje , et al. July 2, 2	2013-07-02
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Grant 8,470,810 - Drescher , et al. June 25, 2	2013-06-25
Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Grant 8,383,641 - Grandel , et al. February 26, 2	2013-02-26
Aminoethylaromatic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor App 20120220635 - Drescher; Karla ; et al.	2012-08-30
Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Grant 8,232,426 - Drescher , et al. July 31, 2	2012-07-31
Tetrahydrobenzazepines and their use in he modulation of the dopamine D.sub.3 receptor Grant 8,207,160 - Braje , et al. June 26, 2	2012-06-26
4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor Grant 8,202,868 - Haupt , et al. June 19, 2	2012-06-19
N-[piperazinyl Hetaryl]arylsufonamide Compounds With Affinity For The Dopamine D3 Receptor App 20110294817 - Braje; Wilfried ; et al.	2011-12-01
Pyridazine compounds as glycogen synthase kinase 3 inhibitors Grant 7,994,160 - Turner , et al. August 9, 2	2011-08-09
Heterocyclic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor App 20110160176 - Drescher; Karla ; et al.	2011-06-30
Aminomethyl Substituted Bicyclic Aromatic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor App 20110144146 - Drescher; Karla ; et al.	2011-06-16
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor Grant 7,851,463 - Drescher , et al. December 14, 2	2010-12-14
Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Grant 7,834,048 - Drescher , et al. November 16, 2	2010-11-16
6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor Grant 7,759,397 - Drescher , et al. July 20, 2	2010-07-20
Heterocyclic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5ht6 Receptor App 20100048582 - Grandel; Roland ; et al.	2010-02-25
Pyridazine Compounds as Glycogen Synthase Kinase 3 Inhibitors App 20090325937 - Turner; Sean C. ; et al.	2009-12-31
Heterocyclic Arylsulphones Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5ht6 Receptor App 20090306175 - Grandel; Roland ; et al.	2009-12-10
4-Piperazinyl-Pyrimidine Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor App 20090264437 - Haupt; Andreas ; et al.	2009-10-22
Aryloxyethylamine Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor App 20090143383 - Grandel; Roland ; et al.	2009-06-04
Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor App 20090105224 - Braje; Wilfried ; et al.	2009-04-23
Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor App 20090048326 - Drescher; Karla ; et al.	2009-02-19
Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the Dopamine D3 receptor App 20090012074 - Drescher; Karla ; et al.	2009-01-08
6-Amino(Aza)Indane Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor App 20080318996 - Drescher; Karla ; et al.	2008-12-25
Aminoethylaromatic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor App 20080096934 - Drescher; Karla ; et al.	2008-04-24
Heterocyclic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor App 20080045493 - Drescher; Karla ; et al.	2008-02-21
N-[(piperazinyl)hetaryl]arylsulfonamide compounds Grant 7,320,979 - Braje , et al. January 22, 2	2008-01-22
Substituted benzimidazoles and their use as PARP inhibitors Grant RE39,608 - Lubisch , et al. May 1, 2	2007-05-01
N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptor App 20070054918 - Braje; Wilfried ; et al.	2007-03-08
Substituted indoles which are PARP inhibitors Grant 7,087,637 - Grandel , et al. August 8, 2	2006-08-08
N-[(piperazinyl)hetaryl]arylsulfonamide compounds App 20060160809 - Braje; Wilfried M. ; et al.	2006-07-20
Heterocyclic compounds and their use as PARP inhibitors Grant 7,041,675 - Lubisch , et al. May 9, 2	2006-05-09
Dibenzodiazepine derivatives, their preparation and use Grant 7,026,311 - Lubisch , et al. April 11, 2	2006-04-11
Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Grant 6,919,342 - Haupt , et al. July 19, 2	2005-07-19
Tetrahydrobenzazepines and their use App 20050137186 - Braje, Wilfried M. ; et al.	2005-06-23
Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor App 20040259882 - Haupt, Andreas ; et al.	2004-12-23
N-[(Piperazinyl)hetaryl]arylsulfonamide compounds App 20040204422 - Braje, Wilfried M. ; et al.	2004-10-14
Cyclo-alkyl substituted benzimidazoles and their use as PARP inhibitors Grant 6,737,421 - Lubish , et al. May 18, 2	2004-05-18
Substituted indoles which are parp inhibitors App 20040067949 - Grandel, Roland ; et al.	2004-04-08
Heterocyclically substituted benzimidazoles, the production and application thereof Grant 6,696,437 - Lubisch , et al. February 24, 2	2004-02-24
Dibenzodiazepine derivatives, their preparation and use App 20030139394 - Lubisch, Wilfried ; et al.	2003-07-24
Heterocyclic compounds and their use as parp inhibitors App 20030134843 - Lubisch, Wilfried ; et al.	2003-07-17
Substituted benzimidazoles and their use as parp inhibitors Grant 6,448,271 - Lubisch , et al. September 10, 2	2002-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.